- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03215472
DASH Cloud: Using Digital Health to Improve Adherence to the DASH Diet Among Women
DASH Cloud: Using Digital Health to Improve Adherence to the DASH Diet Among Women at Risk for Cardiovascular Disease
Study Overview
Status
Intervention / Treatment
Detailed Description
Specifically, this study aims to
- To test the feasibility of the DASH Cloud intervention compared to education control among women with prehypertension and hypertension via a 3-month randomized controlled trial.
- To evaluate the preliminary efficacy of the DASH Cloud intervention relative to education control on blood pressure, weight and medication adherence at 3 months.
This study will enroll 50 adult women aged 21-70 with pre-hypertension or hypertension in a 3-month randomized controlled trial to test the initial feasibility of DASH Cloud. Women will be randomized to either the DASH Cloud intervention or DASH Light and followed up 3 months post randomization. The investigators will recruit participants from the Durham, NC area.
Women randomized to the DASH Cloud intervention will be asked to track their diet daily using a smartphone diet tracking app. Based on the foods/beverages entered, the intervention will send daily or weekly text messages with feedback about DASH adherence and information videos about how to follow DASH. Women randomized to DASH Light will also be asked to track their diet using the smartphone diet tracking app and will receive basic informational materials about DASH.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27708
- The Sarah W. Stedman Nutrition and Metabolism Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ages 21-70 years; BMI >18.5 kg/m2
- on antihypertensive medication or systolic blood pressure 120-159 mmHg and/or diastolic blood pressure of 80-99
- current use of a smartphone and willingness to be texted daily or weekly
- an email account; spoken and written English fluency.
Exclusion Criteria:
- CVD event in prior 6 months
- active malignancy; active psychosis or recent psychiatric institutionalization
- current pregnancy or lactation
- current participation in a similar trial.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: DASH Cloud intervention
In group 1, participants will be instructed to input their dietary intake daily for three months using the Nutritionix app.
A participant's data will automatically be uploaded from the Nutritionix app via the API that links the device with DASH Cloud.
DASH Cloud will run an algorithm and send daily or weekly feedback text messages reflecting DASH adherence.
The intervention components include tailored feedback texts, and behavioral skills training videos.
|
With DASH Cloud, the investigators will ask participants to track their diet daily using a commercial diet tracking app.
The investigators will retrieve the diet data on our DASH Cloud platform and provide tailored feedback about a participant's DASH adherence via fully automated daily or weekly text messages.
These feedback messages will describe both an individual's absolute performance and change over time.
The investigators also include theory-driven tailored content that reinforces successes, offers motivational strategies, and offers short behavior change tips.
|
Experimental: Dash Light
Group 2 participants will be asked to use the Nutritionix app daily and receive publicly available written materials on the DASH diet.
|
DASH Light Control participants will be asked to use the Nutritionix app daily and receive publicly available written materials on the DASH diet.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to the DASH Diet
Time Frame: 3 months
|
Dietary intake data will be collected using NCI's Automated Self-Administered 24-hour Recall tool.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Blood Pressure
Time Frame: Baseline, 3 months
|
Blood pressure will be measured at baseline and 3 months in the upper arm in triplicate at 1-minute intervals.
Measurements will be obtained using the validated Omron HEM-907XL blood pressure monitor.
|
Baseline, 3 months
|
Change in Weight
Time Frame: Baseline, 3 months
|
Weight will be collected in kilograms at baseline and 3 months using a calibrated digital scale.
|
Baseline, 3 months
|
Engagement
Time Frame: 3 months
|
Utilization of intervention component (daily diet tracking using Nutritionix app) at 3 months.
This will be measured by the proportion of participants completing daily dietary self-monitoring.
|
3 months
|
Engagement
Time Frame: 3 months
|
Utilization of intervention component (review of skills training videos) at 3 months.
This will be measured by the number of clicks to skills training via video tracking software.
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dori M Steinberg, PhD, RD, Duke University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00081972
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
Clinical Trials on DASH Cloud
-
Duke UniversityCompletedDiet Modification | Behavior, HealthUnited States
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Women's College HospitalMarkham Stouffville HospitalCompletedChronic Obstructive Pulmonary DiseaseCanada
-
Case Western Reserve UniversityCompleted
-
University of Applied Sciences and Arts of Southern...Vrije Universiteit Brussel; University of PortsmouthCompletedHypoxia | Altitude Sickness | Mountain Sickness | Hypoxia, Altitude | Altitude Hypoxia | AltitudeSwitzerland
-
Peking Union Medical College HospitalBeijing Aerospace General Hospital; People's Hospital of Beijing Daxing District and other collaboratorsRecruitingArtificial Intelligence | Endoscopy | Diagnoses Disease | Quality ControlChina
-
Sun Yat-sen UniversityThe First Affiliated Hospital of Soochow University; The Affilicated Suzhou...Unknown
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHigh Blood PressureUnited States
-
Northwestern UniversityNadi, LLCActive, not recruitingHearing Loss | Hearing Loss, SensorineuralUnited States
-
Scripps Whittier Diabetes InstituteDexCom, Inc.TerminatedDiabetes Mellitus, Type 2United States